FDA Inspection 1249053 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 2076545

The FDA completed an inspection of American Red Cross Blood Services on Jul 3, 2024 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 3, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Santa Ana, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.